Clinical Trials Browser

Phase 2 × Small Cell Lung Cancer Recurrent × Thoracic × Clear all

NCT03823118 2023-02-23

S1 Plus Anlotinib in Treating Patients With Refractory or Relapsed Small-cell Lung Cancer

Phase 2 Completed

Small Cell Lung Cancer Recurrent

NCT03262454 2022-04-06

Atezolizumab

Phase 2 Unknown

Small Cell Lung Cancer Recurrent

NCT02477813 2018-11-13

TeRes

Phase 2 Terminated

Small Cell Lung Cancer Recurrent